These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17603061)

  • 1. Intraumbilical injection of uterotonics for retained placenta.
    Habek D; Franicević D
    Int J Gynaecol Obstet; 2007 Nov; 99(2):105-9. PubMed ID: 17603061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraumbilical injection of three different uterotonics in the management of retained placenta.
    Harara R; Hanafy S; Zidan MS; Alberry M
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of a retained placenta with intraumbilical oxytocin injection.
    Habek D; Hrgović Z; Ivanisević M; Delmis J
    Zentralbl Gynakol; 2001 Jul; 123(7):415-7. PubMed ID: 11534303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial.
    Güngördük K; Asicioglu O; Besimoglu B; Güngördük OC; Yildirm G; Ark C; Tekirdağ AI
    Obstet Gynecol; 2010 Sep; 116(3):619-624. PubMed ID: 20733444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intraumbilical vein oxytocin injection on third stage of labor.
    Nankali A; Keshavarzi F; Fakheri T; Zare S; Rezaei M; Daeichin S
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):57-60. PubMed ID: 23548219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraumbilical veinous injection oxytocin in the active management of third stage of labour.
    Tehseen F; Anwar A; Arfat Y
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):551-4. PubMed ID: 18803892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraumbilical oxytocin for management of retained placenta.
    Makkonen M; Suonio S; Saarikoski S
    Int J Gynaecol Obstet; 1995 Feb; 48(2):169-72. PubMed ID: 7540566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraumbilical vein injection of oxytocin and the third stage of labor: randomized double-blind placebo trial.
    Ghulmiyyah LM; Wehbe SA; Saltzman SL; Ehleben C; Sibai BM
    Am J Perinatol; 2007 Jun; 24(6):347-52. PubMed ID: 17564955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical vein injection for the routine management of third stage of labour.
    Mori R; Nardin JM; Yamamoto N; Carroli G; Weeks A
    Cochrane Database Syst Rev; 2012 Mar; (3):CD006176. PubMed ID: 22419311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-umbilical vein injection of carbetocin versus oxytocin in the management of retained placenta.
    Salem MAA; Saraya YS; Badr MS; Soliman AM
    Sex Reprod Healthc; 2019 Oct; 21():21-25. PubMed ID: 31395229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial.
    Maher MA; Sayyed TM; Elkhouly NI
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2179-2184. PubMed ID: 27677547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical vein injection for management of retained placenta.
    Nardin JM; Weeks A; Carroli G
    Cochrane Database Syst Rev; 2011 May; (5):CD001337. PubMed ID: 21563129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different doses of intraumbilical oxytocin on the third stage of labor.
    Puri M; Taneja P; Gami N; Rehan HS
    Int J Gynaecol Obstet; 2012 Sep; 118(3):210-2. PubMed ID: 22727052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a place for intra-umbilical oxytocin for the management of retained placenta?
    Sivalingam N; Surinder S
    Med J Malaysia; 2001 Dec; 56(4):451-9. PubMed ID: 12014765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial.
    Gazvani MR; Luckas MJ; Drakeley AJ; Emery SJ; Alfirevic Z; Walkinshaw SA
    Obstet Gynecol; 1998 Feb; 91(2):203-7. PubMed ID: 9469276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparative study of prophylactic oxytocin versus ergometrine in the third stage of labor.
    Orji E; Agwu F; Loto O; Olaleye O
    Int J Gynaecol Obstet; 2008 May; 101(2):129-32. PubMed ID: 18164304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2001; (4):CD001337. PubMed ID: 11687109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.